Abstract
Despite advances in HIV treatment, bacterial pneumonia continues to cause considerable morbidity and mortality in patients with HIV infection. Studies of biomarker associations with bacterial pneumonia risk in treated HIV-infected patients do not currently exist.
Original language | English |
---|---|
Journal | P L o S One |
Volume | 8 |
Issue number | 2 |
Pages (from-to) | e56249 |
ISSN | 1932-6203 |
DOIs | |
Publication status | Published - 2013 |
Keywords
- Adult
- Anti-HIV Agents
- Biological Markers
- C-Reactive Protein
- Case-Control Studies
- Female
- Fibrin Fibrinogen Degradation Products
- HIV Infections
- Humans
- Interleukin-6
- Lung
- Male
- Middle Aged
- Pneumonia, Bacterial
- Pulmonary Surfactant-Associated Protein D
- Risk Factors
- Uteroglobin